Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

被引：0
|
作者：
Christine Robin
François Hémery
Christel Dindorf
Julien Thillard
Ludovic Cabanne
Rabah Redjoul
Florence Beckerich
Christophe Rodriguez
Cécile Pautas
Andrea Toma
Sébastien Maury
Isabelle Durand-Zaleski
Catherine Cordonnier
机构：
[1] Assistance Publique-Hopitaux de Paris (APHP),Department of Hematology
[2] Henri Mondor Teaching Hospital,Department of Medical Information
[3] University Paris-Est Créteil (UPEC),Department of Virology, and INSERM U955 Team 18
[4] APHP,Department of Public Health
[5] Henri Mondor Teaching Hospital,undefined
[6] URC-Eco APHP ECEVE UMRS 1123,undefined
[7] APHP,undefined
[8] Henri Mondor Teaching Hospital,undefined
[9] APHP,undefined
[10] Henri Mondor Teaching Hospital,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Allogeneic stem cell transplantation; CMV infection; Antivirals; Costs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients
    Robin, Christine
    Hemery, Francois
    Dindorf, Christei
    Thillard, Julien
    Cabanne, Ludovic
    Redjoul, Rabah
    Beckerich, Florence
    Rodriguez, Christophe
    Pautas, Cecile
    Toma, Andrea
    Maury, Sebastien
    Durand-Zaleski, Isabelle
    Cordonnier, Catherine
    [J]. BMC INFECTIOUS DISEASES, 2017, 17
  • [2] THE CLINICAL AND FINANCIAL BURDEN OF PREEMPTIVE MANAGEMENT OF CMV DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Barrett, A.
    Jain, N.
    Ito, S.
    Lu, K.
    Muranski, P.
    Childs, R.
    Hourigan, C.
    Haggerty, J.
    Ramos, C.
    Cook, L.
    Battiwalla, M.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S331 - S331
  • [3] USE OF CMV HYPERIMMUNOGLOBULINS (CYTOTECT) AS PREEMPTIVE TREATMENT OF CMV INFECTION IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A SINGLE CENTRE EXPERIENCE
    Desnica, Lana
    Durakovic, Nadira
    Peric, Zinaida
    Serventi-Seiwerth, Ranka
    Roncevic, Pavle
    Sertic, Dubravka
    Mikulic, Mirta
    Pulanic, Drazen
    Vrhovac, Radovan
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 430 - 431
  • [4] Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Busca, Alessandro
    Bruno, Benedetto
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 585 - 596
  • [5] Valganciclovir is effective in the preemptive treatment of cytomegalovirus (CMV) infection after allogeneic stem cell transplant (ASCT)
    Aberle, MF
    Bachier, C
    Lemaistre, FC
    Shaughnessy, PJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 136 - 136
  • [6] Cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT)
    Trenschel, R
    Ross, S
    Runde, V
    Retzlaff, S
    Ottinger, H
    Kohl, D
    Roggendorf, M
    Schaefer, UW
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S68 - S68
  • [7] Oral valganciclovir is safe and effective as preemptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
    Ayala, E
    Greene, J
    Sandin, R
    Perkins, J
    Field, T
    Tate, C
    Goldstein, SC
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 31 - 31
  • [8] An experimental and clinical study of CMV infection after allogeneic hematopoietic stem cell transplantation.
    Wu, DP
    Wu, XJ
    Li, CX
    Ma, X
    Sun, AN
    [J]. BLOOD, 2004, 104 (11) : 354B - 354B
  • [9] CMV resistance in patients after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Kouba, M.
    Boutolleau, D.
    Pliskova, L.
    Vejrazkova, E.
    Keslova, P.
    Sedlacek, P.
    Cetkovsky, P.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S125 - S126
  • [10] CMV resistance in patients after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Kouba, M.
    Boutolleau, D.
    Pliskova, L.
    Vejrazkova, E.
    Keslova, P.
    Sedlacek, P.
    Cetkovsky, P.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S78 - S78
12345